Detalhe da pesquisa
1.
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.
Expert Rev Vaccines
; 22(1): 1-16, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36330971
2.
Long-term immunogenicity assessment of a DTaP-IPV//PRP-T vaccine given at 2, 4, 6 and 18-19 months of age, and immunogenicity and safety of a DTaP-IPV vaccine given as a booster dose at 4 to 6 years of age in Thai children.
Southeast Asian J Trop Med Public Health
; 43(3): 687-98, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23077849
3.
Antibody persistence after primary and booster doses of a pentavalent vaccine against diphtheria, tetanus, acellular pertussis, inactivated poliovirus, haemophilus influenzae type B vaccine among Thai children at 18-19 months of age.
Southeast Asian J Trop Med Public Health
; 43(2): 442-54, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23082595
4.
Expert review on global real-world vaccine effectiveness against SARS-CoV-2.
Expert Rev Vaccines
; 21(9): 1255-1268, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748494
5.
Evaluation of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) at 2, 4, and 6 months of age plus hepatitis B vaccine at birth, 2, and 6 months of age in infants in Thailand.
Southeast Asian J Trop Med Public Health
; 41(2): 450-62, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20578530
6.
Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine.
Southeast Asian J Trop Med Public Health
; 40(2): 282-94, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19323013
7.
Evidence of influenza or influenza-like-illness preceding acute coronary syndrome.
Southeast Asian J Trop Med Public Health
; 39(6): 1040-4, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19062692
8.
Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRPâ¼T vaccination at 2, 4 and 6 months.
Hum Vaccin Immunother
; 14(5): 1257-1265, 2018 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29333947
9.
Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine: A Phase IV Study in Thai Children.
Pediatr Infect Dis J
; 36(2): e45-e47, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27846060
10.
Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand.
Vaccine
; 35(2): 299-304, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903416
11.
Further implications on the global real-world vaccine effectiveness against SARS-CoV-2.
Expert Rev Vaccines
; 21(9): 1355-1357, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35968671
12.
Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.
Hum Vaccin Immunother
; 10(7): 1859-65, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25424793